Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
|Articles|March 8, 2022
Daily OTC Pearl: OTC Severe Sinus Medication
Author(s)Saro Arakelians, PharmD
Advertisement
OTC/Lifestyle Pearl of the Day: OTC Severe Sinus Medication
Indication: OTC severe sinus medications offer relief to sinus headaches, help to loosen phlegm, reduces sinus pressure and chest congestions, and temporarily reduces fever.
Insight:
- Warning: This product contains acetaminophen, which can affect the liver. Do not take other products that have acetaminophen in them.
- Maximum acetaminophen consumption: 4000 mg per day.
- Directions: 2 caplets every 4 hours.
- Do not take more than 10 caplets in 24 hours.
- For children under 12, ask a physician.
- Adverse effects: Dizziness, nervousness, redness, and swelling.
Sources:
Advertisement
Related to this article
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Understanding local health care priorities is essential to developing meaningful solutions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5